《中国康复理论与实践》

中国康复理论与实践 >

2020 , Vol. 26 >Issue 3: 339 - 343

DOI: https://doi.org/10.3969/j.issn.1006-9771.2020.03.015

环咽肌失弛缓症的研究进展

  • 张祎辰 ,
  • 高正玉 ,
  • 王强 ,
  • 张春佳 ,
  • 王瞳 ,
  • 罗慧
展开
  • 青岛大学附属医院康复医学科,山东青岛市 266003
张祎辰(1994-),女,汉族,山东聊城市人,硕士,医师,主要研究方向：脑卒中后吞咽障碍。

收稿日期: 2019-10-30

  修回日期: 2020-01-16

  网络出版日期: 2020-04-01

收起

Advance in Cricopharyngeal Dysfunction (review)

  • Yi-chen ZHANG ,
  • Zheng-yu GAO ,
  • Qiang WANG ,
  • Chun-jia ZHANG ,
  • Tong WANG ,
  • Hui LUO
Expand
  • Department of Rehabilitation Medicine, the Affiliated Hopsital of Qingdao University, Qingdao, Shandong 266003, China

Received date: 2019-10-30

  Revised date: 2020-01-16

  Online published: 2020-04-01

Fold

摘要

环咽肌是食管上括约肌的重要组成部分,其功能性开放不完全或完全不能开放而造成的吞咽障碍称为环咽肌失弛缓症(CPD)。神经系统疾病和头颈部肿瘤等均可导致CPD,发病机制尚未完全阐明。CPD的诊断依靠临床表现和吞咽功能评估,如吞咽造影检查、食管测压和电生理检查。食管测压并不是金标准,应与吞咽造影检查结合进行。治疗措施包括吞咽训练、球囊扩张、肉毒毒素注射和环咽肌切开术。喉上抬正常且咽部肌肉功能良好的患者治疗效果通常较好。球囊扩张目前较为常用。环咽肌切开术成功率高于肉毒毒素注射治疗。三种技术各有优缺点,各自的适应症、禁忌症和患者选择等问题有待进一步研究。

关键词： 环咽肌失弛缓症; 发病机制; 诊断; 治疗; 综述

本文引用格式

张祎辰 , 高正玉 , 王强 , 张春佳 , 王瞳 , 罗慧 . 环咽肌失弛缓症的研究进展[J]. 中国康复理论与实践, 2020 , 26(3) : 339 -343 . DOI: 10.3969/j.issn.1006-9771.2020.03.015

Abstract

Cricopharyngeus muscle (CPM) is an important component of upper esophageal sphincter. It is termed cricopharyngeus dysfunction (CPD) if CPM fails to relax, which may be second to neurologic or neoplastic disease. However, the pathogenesis is not yet clear. The diagnosis of CPD would combine clinical features and swallowing evalutions, such as videofluoroscopic swallowing study, pharyngeal manometry and electromyogram, etc. Esophageal manometry is not the golden standard and should be combined with videofluoroscopic swallowing study. Interventions include swallowing exercise, pharyngoesophageal balloon dilatation, Botulinum toxin injection and cricopharyngeus myotomy. The outcomes will be better in those with intact laryngeal elevation and pharyngeal contraction. Balloon dilation is more commonly used. The success rate of cricopharyngeus myotomy is reported higher than that of Botulinum toxin injection. Each of the three technologies has their advantages, and it needs more researches to study their indications, contraindications and patient selection.

Key words： cricopharyngeal dysfunction; pathogenesis; diagnosis; treatment; review

参考文献

[1] Yang H, Yi Y, Han Y, et al. Characteristics of cricopharyngeal dysphagia after ischemic stroke[J]. Ann Rehabil Med, 2018, 42(2):204-212.
[2] Allen J E. Cricopharyngeal function or dysfunction: what's the deal?[J]. Curr Opin Otolaryngol Head Neck Surg, 2016, 24(6):494-499.
[3] Chiu M J, Chang Y C, Hsiao T Y. Prolonged effect of Botulinum toxin injection in the treatment of cricopharyngeal dysphagia: case report and literature review[J]. Dysphagia, 2004, 19(1):52-57.
[4] Moerman M, Callier Y, Dick C, et al. Botulinum toxin for dysphagia due to cricopharyngeal dysfunction[J]. Eur Arch Otorhinolaryngol, 2002, 259(1):1-3.
[5] Belafsky P C, Plowman E K, Mehdizadeh O, et al. The upper esophageal sphincter is not round: a pilot study evaluating a novel, physiology-based approach to upper esophageal sphincter dilation[J]. Ann Otol Rhinol Laryngol, 2013, 122(4):217-221.
[6] Sasaki C T, Kim Y H, Sims H S, et al. Motor innervation of the human cricopharyngeus muscle[J]. Ann Otol Rhinol Laryngol, 1999, 108(12):1132-1139.
[7] Uludag M, Aygun N, Isgor A. Innervation of the human cricopharyngeal muscle by the recurrent laryngeal nerve and external branch of the superior laryngeal nerve[J]. Langenbecks Arch Surg, 2017, 402(4):683-690.
[8] Babaei A, Dua K, Naini S R, et al. Response of the upper esophageal sphincter to esophageal distension is affected by posture, velocity, volume, and composition of the infusate[J]. Gastroenterology, 2012, 142(4):734-743, e737.
[9] Kahrilas P J, Dodds W J, Dent J, et al. Effect of sleep, spontaneous gastroesophageal reflux, and a meal on upper esophageal sphincter pressure in normal human volunteers[J]. Gastroenterology, 1987, 92(2):466-471.
[10] Alfonsi E, Merlo I M, Ponzio M, et al. An electrophysiological approach to the diagnosis of neurogenic dysphagia: implications for Botulinum toxin treatment[J]. J Neurol Neurosurg Psychiatry, 2010, 81(1):54-60.
[11] Haapaniemi J J, Laurikainen E A, Pulkkinen J, et al. Botulinum toxin in the treatment of cricopharyngeal dysphagia[J]. Dysphagia, 2001, 16(3):171-175.
[12] Williams R B, Wallace K L, Ali G N, et al. Biomechanics of failed deglutitive upper esophageal sphincter relaxation in neurogenic dysphagia[J]. Am J Physiol Gastrointest Liver Physiol, 2002, 283(1):G16-26.
[13] Bian R X, Choi I S, Kim J H, et al. Impaired opening of the upper esophageal sphincter in patients with medullary infarctions[J]. Dysphagia, 2009, 24(2):238-245.
[14] Battel I, Koch I, Biddau F, et al. Efficacy of Botulinum toxin type-A and swallowing treatment for oropharyngeal dysphagia recovery in a patient with lateral medullary syndrome[J]. Eur J Phys Rehabil Med, 2017, 53(5):798-801.
[15] Prisman E, Miles B A, Genden E M. Prevention and management of treatment-induced pharyngo-oesophageal stricture[J]. Lancet Oncol, 2013, 14(9):e380-386.
[16] Regan J, Murphy A, Chiang M, et al. Botulinum toxin for upper oesophageal sphincter dysfunction in neurological swallowing disorders[J]. Cochrane Database Syst Rev, 2014, 5(5):CD009968.
[17] Ertekin C, Turman B, Tarlaci S, et al. Cricopharyngeal sphincter muscle responses to transcranial magnetic stimulation in normal subjects and in patients with dysphagia[J]. Clin Neurophysiol, 2001, 112(1):86-94.
[18] Kahrilas P J, Dodds W J, Dent J, et al. Upper esophageal sphincter function during deglutition[J]. Gastroenterology, 1988, 95(1):52-62.
[19] Olsson R, Nilsson H, Ekberg O. An experimental manometric study simulating upper esophageal sphincter narrowing[J]. Invest Radiol, 1994, 29(6):630-635.
[20] Ahsan S F, Meleca R J, Dworkin J P. Botulinum toxin injection of the cricopharyngeus muscle for the treatment of dysphagia[J]. Otolaryngol Head Neck Surg, 2000, 122(5):691-695.
[21] 王修敏, 夏清. 环咽肌失弛缓症与环咽肌功能障碍辨析[J]. 中华物理医学与康复杂志, 2016, 38(12):958-960.
[22] Terre R, Panades A, Mearin F. Botulinum toxin treatment for oropharyngeal dysphagia in patients with stroke[J]. Neurogastroenterol Motil, 2013, 25(11):896-e702.
[23] Goyal R K, Martin S B, Shapiro J, et al. The role of cricopharyngeus muscle in pharyngoesophageal disorders[J]. Dysphagia, 1993, 8(3):252-258.
[24] Omari T, Kritas S, Cock C. New insights into pharyngo-esophageal bolus transport revealed by pressure-impedance measurement[J]. Neurogastroenterol Motil, 2012, 24(11):e549-556.
[25] Cock C, Besanko L, Kritas S, et al. Maximum upper esophageal sphincter (UES) admittance: a non-specific marker of UES dysfunction[J]. Neurogastroenterol Motil, 2016, 28(2):225-233.
[26] Arenaz Bua B, Olsson R, Westin U, et al. Treatment of cricopharyngeal dysfunction: a comparative pilot study[J]. BMC Res Notes, 2015, 8(1):301.
[27] 金琳娜, 廖志平, 邹朝君. 导管球囊扩张术治疗脑卒中患者环咽肌功能障碍的研究进展[J]. 中华物理医学与康复杂志, 2018, 40(12):957-960.
[28] Chandrasekhara V, Koh J, Lattimer L, et al. Endoscopic balloon catheter dilatation via retrograde or static technique is safe and effective for cricopharyngeal dysfunction[J]. World J Gastrointest Endosc, 2017, 9(4):183-188.
[29] Solt J, Bajor J, Moizs M, et al. Primary cricopharyngeal dysfunction: treatment with balloon catheter dilatation[J]. Gastrointest Endosc, 2001, 54(6):767-771.
[30] Schneider I, Thumfart W F, Pototschnig C, et al. Treatment of dysfunction of the cricopharyngeal muscle with Botulinum A toxin: introduction of a new, noninvasive method[J]. Ann Otol Rhinol Laryngol, 1994, 103(1):31-35.
[31] Kim M S, Kim G W, Rho Y S, et al. Office-based electromyography-guided Botulinum toxin injection to the cricopharyngeus muscle: optimal patient selection and technique[J]. Ann Otol Rhinol Laryngol, 2017, 126(5):349-356.
[32] Lau K, Watson M G. Pharyngeal pouch: comparison of surgical treatment with Botulinum toxin injection to the cricopharyngeus[J]. J Laryngol Otol, 2019, 133(2):125-128.
[33] Jeong S H, Kim Y J, Kim Y J, et al. Endoscopic Botulinum toxin injection for treatment of pharyngeal dysphagia in patients with cricopharyngeal dysfunction[J]. Scand J Gastroenterol, 2018, 53(10-11):1201-1205.
[34] Sharma S D, Kumar G, Eweiss A, et al. Endoscopic-guided injection of Botulinum toxin into the cricopharyngeus muscle: our experience[J]. J Laryngol Otol, 2015, 129(10):990-995.
[35] Krause E, Schirra J, Gurkov R. Botulinum toxin a treatment of cricopharyngeal dysphagia after subarachnoid hemorrhage[J]. Dysphagia, 2008, 23(4):406-410.
[36] Restivo D A, Marchese-Ragona R, Patti F, et al. Botulinum toxin improves dysphagia associated with multiple sclerosis[J]. Eur J Neurol, 2011, 18(3):486-490.
[37] Woisard-Bassols V, Alshehri S, Simonetta-Moreau M. The effects of Botulinum toxin injections into the cricopharyngeus muscle of patients with cricopharyngeus dysfunction associated with pharyngo-laryngeal weakness[J]. Eur Arch Otorhinolaryngol, 2013, 270(3):805-815.
[38] 岳寿伟, 怀娟, 关家文, 等. 食管球囊造影联合CT引导下环咽肌肉毒毒素注射治疗脑干损伤后吞咽障碍1例报告[J]. 中国康复医学杂志, 2017, 32(9):1046-1048.
[39] 张学敏, 毕胜, 许亚飞, 等. 超声引导下A型肉毒毒素注射治疗脑干梗死环咽肌失弛缓症1例报告[J]. 中国康复医学杂志, 2019, 34(2):216-218.
[40] Wang Y C, Shyu S G, Wu C H, et al. Ultrasound-guided injection of Botulinum toxin for cricopharyngeal dysphagia[J]. Am J Phys Med Rehabil, 2018, 97(10):e102-e103.
[41] 林晓婷, 杨海云, 栗晓, 等. 超声引导肉毒毒素注射治疗环咽肌功能障碍探讨[J]. 中山大学学报(医学版), 2018, 39(3):472-476.
[42] Kang S H, Kim J S, Joo J S, et al. Efficacy of early endoscopic intervention for restoring normal swallowing function in patients with lateral medullary infarction[J]. Toxins (Basel), 2019, 11(3):E144.
[43] Kelly E A, Koszewski I J, Jaradeh S S, et al. Botulinum toxin injection for the treatment of upper esophageal sphincter dysfunction[J]. Ann Otol Rhinol Laryngol, 2013, 122(2):100-108.
[44] Alfonsi E, Restivo D A, Cosentino G, et al. Botulinum toxin is effective in the management of neurogenic dysphagia. Clinical-electrophysiological findings and tips on safety in different neurological disorders[J]. Front Pharmacol, 2017, 8:80.
[45] Kocdor P, Siegel E R, Tulunay-Ugur O E. Cricopharyngeal dysfunction: a systematic review comparing outcomes of dilatation, Botulinum toxin injection, and myotomy[J]. Laryngoscope, 2016, 126(1):135-141.
[46] Kaplan S. Paralysis of deglutition, a post-poliomyelitis complication treated by section of the cricopharyngeus muscle[J]. Ann Surg, 1951, 133(4):572-573.
[47] Kelly J H. Management of upper esophageal sphincter disorders: indications and complications of myotomy[J]. Am J Med, 2000, 108(Suppl 4a):43S-46S.
[48] Gilheaney O, Kerr P, Bechet S, et al. Effectiveness of endoscopic cricopharyngeal myotomy in adults with neurological disease: systematic review[J]. J Laryngol Otol, 2016, 130(12):1077-1085.
[49] Kuhn M A, Belafsky P C. Management of cricopharyngeus muscle dysfunction[J]. Otolaryngol Clin North Am, 2013, 46(6):1087-1099.
[50] Huntley C, Boon M, Spiegel J, Open vs. endoscopic cricopharyngeal myotomy; Is there a difference?[J]. Am J Otolaryngol, 2017, 38(4):405-407.
[51] Tieu B H, Hunter J G. Management of cricopharyngeal dysphagia with and without Zenker's diverticulum[J]. Thorac Surg Clin, 2011, 21(4):511-517.
[52] Hoesseini A, Honings J, Taus-Mohamedradja R, et al. Outcomes of endoscopic cricopharyngeal myotomy with CO2 laser surgery: a retrospective study of 47 patients[J]. Head Neck, 2016, 38(7):1022-1027.
[53] Pera M, Yamada A, Hiebert C A, et al. Sleeve recording of upper esophageal sphincter resting pressures during cricopharyngeal myotomy[J]. Ann Surg, 1997, 225(2):229-234.
[54] Abu-Ghanem S, Sung C K, Junlapan A, et al. Endoscopic management of postradiation dysphagia in head and neck cancer patients: a systematic review[J]. Ann Otol Rhinol Laryngol, 2019, 128(8):767-773.
Options
文章导航

/

〈 〉